←
ALK+ International2,328 posts
ALK+ International avatar

ALK+ International

@ALKpositiveINT

Charity focused on funding & advocating for #research to improve the life expectancy of ALK+ #CancerPatients. #TogetherWeCan further ALK+ cancer research

◷ Joined March 2022▧ 272 Photos and videos
Cancer Watch avatar
⟳ ALK+ International retweeted
Cancer Watch@Cancer_watch·12 Jun 2025

New @US_FDA approval for #ros1 #lungcancer #taletrectinib based on TRUST-II looks promising clinical data and great to have more drugs in this area @LungCancer_Bio @LungAssociation @OncoAlert @ros1cancer @ros1dersuk @ALKpositiveINT @ALKPositiveinc fda.gov/drugs/resources-info…

ALK+ International avatar
ALK+ International@ALKpositiveINT·2 Apr 2025

ALK+ International needs you to invest in hope today and donate to vital medical research into ALK+ cancer. Like, share and follow us across all social media platforms to show your support 💙🩵🩷 Whatever you do, big or small makes a difference, join us and take #ACTION4ALK

0:08
OncoDaily avatar
⟳ ALK+ International retweeted
OncoDaily@oncodaily·6 Mar 2025

A Journey of Hope: Norman Ng’s Inspiring Story In this episode of OncoInfluencers, @JArakelyan28092 interviews lung cancer survivor Norman Ng, who shares his journey with stage 4 lung cancer, his advocacy work, and his efforts in advancing ALK inhibitors in Hong Kong while emphasizing early detection and patient support. oncodaily.com/dialogues/2512… #PatientSupport #LungCancer #LCSM #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Post attachment
Stephen Chun avatar
⟳ ALK+ International retweeted
Stephen Chun@StephenChunMD·8 Mar 2025

One of my first papers now cited >100x was on EML4-ALK published in Cancer Biology and Therapy as cover image/story thanks to you @weldeiry tandfonline.com/doi/full/10.… @BobTimmermanMD @IyengarPuneeth @UTSW_RadOnc @MDAndersonNews

CancerNetwork® avatar
⟳ ALK+ International retweeted
CancerNetwork®@CancerNetwrk·8 Mar 2025

Dr. Edward Garon discusses the circumstances that might lead him to switch a patient with ALK+ NSCLC from another ALK inhibitor to lorlatinib. #NSCLC cancernetwork.com/view/evalu…

Dr. Robert avatar
⟳ ALK+ International retweeted
Dr. Robert@robt_heartdoc·11 Mar 2025

The review's deep dive into ALK's oncogenic role and emerging resistance to inhibitors is a call to action for innovative cancer therapies. As a cardiologist, I champion the need for sustained research investment, crucial for advancing patient care amidst the UK's challenging funding landscape.

Teens get cancer too avatar
⟳ ALK+ International retweeted
Teens get cancer too@trials4now·11 Mar 2025

Ultra-deep sequencing of high-risk neuroblastomas found oncogenic aberrations are more prevalent at diagnosis than once thought. ALK and RAS pathway aberrations confer inferior outcomes, emphasizing the need for novel therapeutic approaches. ascopost.com/news/march-2025…

ALK+ International avatar
ALK+ International@ALKpositiveINT·18 Mar 2025

ALK+ International is looking for Volunteers! Passionate about ALK+ cancer research? Social media experience? Want to get involved with advocacy? If you believe that research saves lives come and join our team and help us further ALK+ cancer research. #Action4Alk #TogetherWeCan

Post attachment